Covered recipient · General Payments record
BARBARA E RIZZARDI
Allopathic & Osteopathic Physicians Internal Medicine
General Payments · PY2018–2024
$16,876.78
- Reported across 224 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Travel and Lodging | $2,219.98 | 7 |
| Food and Beverage | $808.83 | 10 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Amgen Inc. | $1,797.85 | 5 |
| Merck Sharp & Dohme Corporation | $1,204.15 | 11 |
| ABBVIE INC. | $26.81 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (17)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $26.81 | 03/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105955196 | CMS |
| Amgen Inc. | $27.99 | 02/23/2024 | Travel and Lodging | Undisputed | 01/23/2026 | 1111689220 | CMS |
| Amgen Inc. | $275.00 | 02/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1111689222 | CMS |
| Amgen Inc. | $562.74 | 02/23/2024 | Travel and Lodging | Undisputed | 01/23/2026 | 1111689224 | CMS |
| Amgen Inc. | $845.70 | 02/23/2024 | Travel and Lodging | Undisputed | 01/23/2026 | 1111689226 | CMS |
| Amgen Inc. | $86.42 | 02/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1111689228 | CMS |
| Merck Sharp & Dohme LLC | $29.13 | 06/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1141556954 | CMS |
| Merck Sharp & Dohme LLC | $32.35 | 06/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1141556956 | CMS |
| Merck Sharp & Dohme LLC | $29.14 | 09/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1141818537 | CMS |
| Merck Sharp & Dohme LLC | $117.51 | 10/01/2024 | Travel and Lodging | Undisputed | 01/23/2026 | 1141764973 | CMS |
| Merck Sharp & Dohme LLC | $233.43 | 10/01/2024 | Travel and Lodging | Undisputed | 01/23/2026 | 1141764975 | CMS |
| Merck Sharp & Dohme LLC | $149.99 | 10/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1141764981 | CMS |
| Merck Sharp & Dohme LLC | $117.51 | 10/01/2024 | Travel and Lodging | Undisputed | 01/23/2026 | 1141890922 | CMS |
| Merck Sharp & Dohme LLC | $54.99 | 10/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1141764977 | CMS |
| Merck Sharp & Dohme LLC | $65.00 | 10/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1141764979 | CMS |
| Merck Sharp & Dohme LLC | $60.00 | 10/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1141890920 | CMS |
| Merck Sharp & Dohme LLC | $315.10 | 10/03/2024 | Travel and Lodging | Undisputed | 01/23/2026 | 1141764983 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.